Showing all news

Poster presented at Essential Protein Engineering Summit 2015

Patel, S., Fernandes, C., Camelo, A., Brown, R., Bartlett, N.W., Johnson, S.L., Barlow, J., McKenzie, A., Matthews, D., (2015). A humanized anti-IL-17BR monoclonal antibody with wide therapeutic potential in allergic asthma, ulcerative colitis, pulmonary fibrosis and pancreatic cancer. In PEGS (Boston) Conference, 4-8 May 2015, Boston USA

19 May 2015

Dementia care digital platform launched by partnership including MRC Technology

Brain health company IXICO launched a digital platform, Project Cygnus, to support patients with the diseases that cause dementia. IXICO is the lead partner in the project, working alongside MRC Technology, The Northern Health Science Alliance Network (NHSA) and several NHS Trusts in the North of England. The project is part-funded by Innovate UK (formerly the Technology Strategy Board).

30 April 2015

MRC Technology appoints Finance Director

MRC Technology has appointed Andrew Mercieca as its Finance Director from 1 April 2015. Andrew joined the company as Interim Finance Director in August 2014.

17 April 2015

Immunotherapy: boosting your body to fight cancer

The basic idea behind immunotherapy for cancer is to stimulate the body’s immune system to attack a cancer rather than the drug directly targeting the diseased cells. Antibodies such as Herceptin, for example, direct a specific attack on cancerous breast cells but a new generation of antibody drugs can also mediate this immunotherapy approach.

10 March 2015

Respiratory ‘Call for Targets’ launched

‘Call for targets’ launched to find new therapeutic concepts for treatment of respiratory disease, including conditions such as allergy, acute respiratory distress syndrome (ARDS), asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and cystic fibrosis.

2 March 2015
Showing all news